Healthcare -
Biotechnology - NASDAQ - US
$ 1.605
11.5 %
$ 15.1 M
Market Cap
-0.19
P/E
GOVX - COST OF REVENUE
Cost of Revenue GOVX - GeoVax Labs, Inc.
20.7 M
LAST VALUE
15.42%
2 YEAR CAGR
61.63%
5 YEAR CAGR
21.67%
10 YEAR CAGR